Your browser doesn't support javascript.
loading
Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia.
Hagger, Martin S; Hardcastle, Sarah J; Hu, Miao; Kwok, See; Lin, Jie; Nawawi, Hapizah M; Pang, Jing; Santos, Raul D; Soran, Handrean; Su, Ta-Chen; Tomlinson, Brian; Watts, Gerald F.
Afiliação
  • Hagger MS; Health Psychology and Behavioural Medicine Research Group, School of Psychology, Curtin University, Perth, Western Australia, Australia; Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland; School of Applied Psychology, Griffith University, Brisbane, Australia. Electron
  • Hardcastle SJ; Health Psychology and Behavioural Medicine Research Group, School of Psychology, Curtin University, Perth, Western Australia, Australia.
  • Hu M; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region.
  • Kwok S; Cardiovascular Trials Unit, The Old St Mary's Hospital, Central Manchester University Hospital NHS Foundation Trust, Manchester, UK; Lipoprotein Research Group, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, University of Manchester, Manch
  • Lin J; Department of Atherosclerosis, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Nawawi HM; Institute for Pathology, Laboratory and Forensic Medicine (I-PPerForM) and Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia.
  • Pang J; School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.
  • Santos RD; Lipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital, Preventive Medicine Centre, Cardiology Program Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Soran H; Cardiovascular Trials Unit, The Old St Mary's Hospital, Central Manchester University Hospital NHS Foundation Trust, Manchester, UK.
  • Su TC; Department of Internal Medicine and Cardiovascular Centre and College of Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Tomlinson B; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region.
  • Watts GF; School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia; Lipid Disorders Clinic, Cardiometabolic Service, Department of Cardiology, Royal Perth Hospital, Perth, Australia.
Atherosclerosis ; 277: 493-501, 2018 10.
Article em En | MEDLINE | ID: mdl-30270090
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autocuidado / Conhecimentos, Atitudes e Prática em Saúde / Intenção / Adesão à Medicação / Hiperlipoproteinemia Tipo II / LDL-Colesterol / Anticolesterolemiantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autocuidado / Conhecimentos, Atitudes e Prática em Saúde / Intenção / Adesão à Medicação / Hiperlipoproteinemia Tipo II / LDL-Colesterol / Anticolesterolemiantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article